Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model
暂无分享,去创建一个
S. Onozawa | S. Murata | H. Tajima | H. Hayashi | Kazuhiro Nomura | R. Kimata | Yutaka Abe | F. Uchiyama
[1] H. Wanebo,et al. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with the balloon-occlusion technique , 1996, Annals of Surgical Oncology.
[2] Y. Kondo,et al. Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in-out flow rate in a pig model , 2005, Journal of Cancer Research and Clinical Oncology.
[3] H. Wanebo,et al. Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug , 2005, Cancer Chemotherapy and Pharmacology.
[4] H. Wanebo,et al. Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer , 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[5] H. Wanebo,et al. A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion , 1999, Cancer Chemotherapy and Pharmacology.
[6] K. Aigner,et al. Pharmacokinetics of Mitomycin C in Pelvic Stopflow Infusion and Hypoxic Pelvic Perfusion with and without Hemofiltration: A Pilot Study of Patients with Recurrent Unresectable Rectal Cancer , 1998, Journal of clinical pharmacology.
[7] H. Wanebo,et al. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. , 1993, Archives of surgery.
[8] A. Wile,et al. Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. , 1987, Archives of surgery.
[9] E. Stemmer,et al. Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J M Collins,et al. Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Slavik,et al. Chemotherapy of cancer , 1977 .
[12] H. Randall,et al. Regional perfusion of pelvis and abdomen by an indirect technique , 1963, Acta - Unio Internationalis Contra Cancrum.
[13] P. Kuehn,et al. Regional perfusion of the pelvis: consideration of the "leakage" problem. , 1961, Surgery.
[14] E. Watkins,et al. The use of intravascular balloon catheters for isolation of the pelvic vascular bed during pump-oxygenator perfusion of cancer chemotherapeutic agents. , 1960, Surgery, gynecology & obstetrics.
[15] R. T. Parker,et al. Abdominal Perfusion for Cancer Chemotherapy. , 1960, Annals of surgery.
[16] J. Stehlin,et al. Regional chemotherapy for cancer: experiences with 116 perfusions. , 1960, Annals of surgery.
[17] A. Monaco,et al. Treatment of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. , 1959, The New England journal of medicine.
[18] R. F. Ryan,et al. Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.